Placebo controlled study to assess the effect of Roflumilast in hyperinflated COPD patients in addition to LABA/LAMA therapy using Functional Respiratory Imaging.
Phase of Trial: Phase II
Latest Information Update: 08 Jan 2018
At a glance
- Drugs Roflumilast (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors FLUIDDA
- 06 Jan 2018 Status changed from recruiting to completed.
- 26 May 2015 New trial record